Award
National Cancer Institute 11210538
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
Recipient
University of California-Irvine
Award Amount
$80,303.00
Ceiling
$80,303.00
Awarded
August 27, 2025
Identifier
11210538
Research project funded by the National Cancer Institute to develop therapeutics targeting cisplatin-induced neurotoxicity, focusing on female mice models and involving various biological analyses.
Description
The project aims to develop therapeutics to reduce cisplatin neurotoxicity, focusing on female mice models due to health disparities. It involves in vitro and in vivo analysis, behavioral testing, and gait analysis. The funding is from the National Cancer Institute (NCI), part of NIH, with a project duration from July 1, 2025, to June 30, 2027.